Soleus Capital Management, L.P. Novo Cure LTD Transaction History
Soleus Capital Management, L.P.
- $1.29 Billion
- Q2 2025
A detailed history of Soleus Capital Management, L.P. transactions in Novo Cure LTD stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 6,904,302 shares of NVCR stock, worth $83.9 Million. This represents 9.53% of its overall portfolio holdings.
Number of Shares
6,904,302
Previous 5,521,414
25.05%
Holding current value
$83.9 Million
Previous $98.4 Million
24.91%
% of portfolio
9.53%
Previous 8.14%
Shares
19 transactions
Others Institutions Holding NVCR
# of Institutions
284Shares Held
77.5MCall Options Held
943KPut Options Held
155K-
Black Rock Inc. New York, NY12.1MShares$147 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$131 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA6.38MShares$77.6 Million0.02% of portfolio
-
State Street Corp Boston, MA2.68MShares$32.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.44MShares$29.7 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.28B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...